CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 104  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0588
LYS 10.0100
GLU 20.0085
LEU 30.0139
ARG 40.0188
CYS 50.0152
GLN 60.0109
CYS 70.0271
ILE 80.0336
LYS 90.0321
THR 100.0486
TYR 110.0335
SER 120.0137
LYS 130.0316
PRO 140.0473
PHE 150.0292
HIS 160.0207
PRO 170.0173
LYS 180.0588
PHE 190.0432
ILE 200.0087
LYS 210.0151
GLU 220.0212
LEU 230.0088
ARG 240.0116
VAL 250.0060
ILE 260.0111
GLU 270.0206
SER 280.0212
GLY 290.0249
PRO 300.0251
HIS 310.0113
CYS 320.0077
ALA 330.0267
ASN 340.0131
THR 350.0126
GLU 360.0057
ILE 370.0063
ILE 380.0060
VAL 390.0057
LYS 400.0100
LEU 410.0109
SER 420.0115
ASP 430.0200
GLY 440.0119
ARG 450.0275
GLU 460.0106
LEU 470.0127
CYS 480.0251
LEU 490.0145
ASP 500.0274
PRO 510.0114
LYS 520.0350
GLU 530.0138
ASN 540.0378
TRP 550.0156
VAL 560.0158
GLN 570.0304
ARG 580.0219
VAL 590.0110
VAL 600.0123
GLU 610.0021
LYS 620.0071
PHE 630.0100
LEU 640.0073
LYS 650.0208
ARG 660.0110
ALA 670.0136
GLU 680.0149
ASN 690.0221

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.